Integer Holdings Co. (NYSE:ITGR) Shares Acquired by Versant Capital Management Inc

Versant Capital Management Inc increased its position in shares of Integer Holdings Co. (NYSE:ITGR) by 98.4% during the 4th quarter, HoldingsChannel.com reports. The firm owned 369 shares of the medical equipment provider’s stock after purchasing an additional 183 shares during the period. Versant Capital Management Inc’s holdings in Integer were worth $49,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also recently added to or reduced their stakes in ITGR. Contravisory Investment Management Inc. raised its position in shares of Integer by 55.9% during the 3rd quarter. Contravisory Investment Management Inc. now owns 223 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 80 shares during the period. Huntington National Bank increased its position in Integer by 8,933.3% in the third quarter. Huntington National Bank now owns 271 shares of the medical equipment provider’s stock worth $35,000 after buying an additional 268 shares during the period. Quest Partners LLC lifted its stake in Integer by 3,688.9% in the second quarter. Quest Partners LLC now owns 341 shares of the medical equipment provider’s stock valued at $39,000 after buying an additional 332 shares during the last quarter. GAMMA Investing LLC boosted its holdings in shares of Integer by 74.1% during the third quarter. GAMMA Investing LLC now owns 653 shares of the medical equipment provider’s stock valued at $85,000 after acquiring an additional 278 shares during the period. Finally, Larson Financial Group LLC grew its position in shares of Integer by 20,000.0% during the third quarter. Larson Financial Group LLC now owns 1,005 shares of the medical equipment provider’s stock worth $131,000 after acquiring an additional 1,000 shares during the last quarter. Institutional investors and hedge funds own 99.29% of the company’s stock.

Analysts Set New Price Targets

ITGR has been the topic of several recent research reports. Wells Fargo & Company reiterated an “overweight” rating and issued a $160.00 price objective on shares of Integer in a research report on Tuesday, December 3rd. KeyCorp lifted their price target on Integer from $139.00 to $144.00 and gave the company an “overweight” rating in a report on Tuesday, October 15th. Citigroup increased their price objective on Integer from $130.00 to $145.00 and gave the stock a “neutral” rating in a report on Wednesday, December 11th. Piper Sandler reaffirmed an “overweight” rating and set a $140.00 target price (up previously from $125.00) on shares of Integer in a research note on Friday, October 25th. Finally, Benchmark increased their price target on Integer from $130.00 to $140.00 and gave the stock a “buy” rating in a research note on Monday, October 21st. One equities research analyst has rated the stock with a hold rating and eight have given a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $145.44.

Integer Trading Down 0.4 %

NYSE:ITGR opened at $133.41 on Tuesday. The company’s 50 day moving average is $135.34 and its 200-day moving average is $127.40. The company has a quick ratio of 2.09, a current ratio of 3.28 and a debt-to-equity ratio of 0.67. Integer Holdings Co. has a 12 month low of $94.56 and a 12 month high of $142.76. The firm has a market cap of $4.47 billion, a price-to-earnings ratio of 41.18, a P/E/G ratio of 1.99 and a beta of 1.12.

Integer (NYSE:ITGR) last issued its quarterly earnings results on Thursday, October 24th. The medical equipment provider reported $1.43 earnings per share for the quarter, beating analysts’ consensus estimates of $1.36 by $0.07. Integer had a net margin of 6.70% and a return on equity of 11.63%. The firm had revenue of $431.42 million during the quarter, compared to the consensus estimate of $440.59 million. During the same period in the prior year, the firm earned $1.27 EPS. The business’s revenue was up 8.7% on a year-over-year basis. Equities analysts anticipate that Integer Holdings Co. will post 5.33 EPS for the current year.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.